DarioHealth Corp.
NASDAQDRIO enters its Q1 2026 earnings report today with an unusual setup for a small-cap health tech name: short sellers have been cutting positions aggressively, even as the stock has shown signs of life. The borrow market signals little conviction from the bear camp. Short interest is just under 1% of free float — a negligible level that does not represent meaningful structural short…
Snapshot as of 14 May 2026
DRIO enters its Q1 2026 earnings report today with an unusual setup for a small-cap health tech name: short sellers have been cutting positions aggressively, even as the stock has shown signs of life. The borrow market…
DarioHealth Corp. heads into the close of a pivotal week with the stock up nearly 9% — and fresh Q1 earnings beats adding momentum to what has already been a strong month. Q1 results, reported this morning, delivered a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DRIO — free to start on ORTEX.
Sign up for free →Open DRIO on ORTEX